Laboratoires d'hématologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


358 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | ...
 
Bleeding heralding the diagnosis of essential thrombocythemia.
Stalder G., Grandoni F., Alberio L. European journal of internal medicine. Peer-reviewed.
 
Intrinsic coagulant potential modulates anticoagulant efficacy of rivaroxaban
Pereira Portela Cindy, Stirnimann Guido, Kröll Dino, Aliotta Alessandro, Veuthey Lucas, Zermatten Maxime G., Alberio Lorenzo, Bertaggia Calderara Debora, 2024/05. Thrombosis Research, 237 pp. 34-36. Peer-reviewed.
 
Increase of Phosphoprotein Expressions in Amotosalen/UVA-Treated Platelet Concentrates.
Muret C., Crettaz D., Alberio L., Prudent M., 2024/04. Transfusion medicine and hemotherapy, 51 (2) pp. 101-110. Peer-reviewed.
 
Ischemic Stroke in Cancer: Mechanisms, Biomarkers, and Implications for Treatment.
Costamagna G., Navi B.B., Beyeler M., Hottinger A.F., Alberio L., Michel P., 2024/04. Seminars in thrombosis and hemostasis, 50 (3) pp. 342-359. Peer-reviewed.
 
Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia.
Spertini C., Bénéchet A.P., Birch F., Bellotti A., Román-Trufero M., Arber C., Auner H.W., Mitchell R.A., Spertini O., Smirnova T., 2024/03/28. Cell death discovery, 10 (1) p. 157. Peer-reviewed.
 
Deep blue.
Dereme J., Segot A., 2024/03/21. Blood, 143 (12) p. 1198. Peer-reviewed.
 
Diagnostic value of antibody-induced procoagulant platelets in heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology.
Zlamal J., Aliotta A., Alberio L., Chen V., Bakchoul T., SSC Platelet Immunology of the ISTH, 2024/03. Journal of thrombosis and haemostasis, 22 (3) pp. 860-868. Peer-reviewed.
 
Philadelphia chromosome-positive B cell acute lymphoblastic phase arising 24 years after treatment-free remission for chronic myeloid leukemia with identical BCR-ABL fusion transcript.
Dereme J., Voruz S., Solly F., Schoumans J., Blum S., 2024/03. Annals of hematology, 103 (3) pp. 1027-1029. Peer-reviewed.
 
Evaluation of the Sysmex XQ-320 three-part differential haematology analyser and its flagging capabilities.
Coutaz C., Mamin A., Mintzas K., 2024/02. Journal of clinical laboratory analysis, 38 (4) pp. e25017. Peer-reviewed.
Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms.
Pritchard J.E., Pearce J.E., Snoeren IAM, Fuchs SNR, Götz K., Peisker F., Wagner S., Benabid A., Lutterbach N., Klöker V. et al., 2024/01/23. Cell reports, 43 (1) p. 113608. Peer-reviewed.
 
Inhibition of mitochondrial calcium transporters alters adp-induced platelet responses.
Shehwar D., Barki S., Aliotta A., Veuthey L., Bertaggia Calderara D., Alberio L., Alam M.R., 2024/01/22. Molecular biology reports, 51 (1) p. 177. Peer-reviewed.
Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure.
Schönborn L., Esteban O., Wesche J., Dobosz P., Broto M., Puig S.R., Fuhrmann J., Torres R., Serra J., Llevadot R. et al., 2023/12/28. Blood, 142 (26) pp. 2305-2314. Peer-reviewed.
MarrowCellDLD: a microfluidic method for label-free retrieval of fragile bone marrow-derived cells.
Porro G., Sarkis R., Obergozo C., Godot L., Amato F., Humbert M., Naveiras O., Guiducci C., 2023/12/18. Scientific reports, 13 (1) p. 22462. Peer-reviewed.
 
Invariant finding of non-clonal bone marrow lymphocytosis, with increased B cell component, in indolent systemic mastocytosis.
Papadopoulou V., Barcena-Garcia C., Basset V., Schoumans J., de Leval L., Schaller M., 2023/12. International journal of laboratory hematology, 45 (6) pp. 1007-1010. Peer-reviewed.
Refined cytogenetic IPSS-R evaluation by the use of SNP array in a cohort of 290 MDS patients.
Scarpelli I., Stalder V.B., Tsilimidos G., Rapakko K., Costanza M., Blum S., Schoumans J., 2023/12. Genes, chromosomes & cancer, 62 (12) pp. 721-731. Peer-reviewed.
 
Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes.
Papadopoulou V., Schoumans J., Basset V., Solly F., Pasquier J., Blum S., Spertini O., 2023/12. Hematology, 28 (1) p. 2180704. Peer-reviewed.
 
Effets secondaires des inhibiteurs de tyrosine kinase dans la leucémie myéloïde chronique [Recognizing and managing side effects of tyrosine kinase inhibitors in chronic myeloid leukemia]
Dereme J., Ségot A., Friedrich N., Tsilimidos G., Blum S., 2023/11/15. Revue medicale suisse, 19 (850) pp. 2175-2181. Peer-reviewed.
 
Bilan hématologique en cas de fausses couches précoces à répétition : quelles évidences ? [Hematological workup in cases of recurrent early miscarriages: what evidences?]
Choffat D., Legardeur H., Grandoni F., Alberio L., Surbone A., Baud D., Gavillet M., 2023/10/18. Revue medicale suisse, 19 (846) pp. 1911-1914. Peer-reviewed.
 
Comparative analysis of automated cell counts in oncological patients: Reliable results of point of care blood impedance measurements and pitfalls in myelodysplastic neoplasias and acute myeloid leukemias.
Blum S., Costanza M., Coutaz C., Naveiras O., Spertini O., Tsilimidos G., Alberio L., 2023/10. International journal of laboratory hematology, 45 (5) pp. 818-821. Peer-reviewed.
 
Pharmacodynamics Monitoring of Emicizumab in Patients with Hemophilia A.
Bertaggia Calderara D., Marchi Cappelletti R., Batista Mesquita Sauvage A.P., Durual S., Gomez F.J., Zermatten M.G., Aliotta A., Casini A., Alberio L., 2023/10. Thrombosis and haemostasis, 123 (10) pp. 955-965. Peer-reviewed.
Pseudo-macrocytosis in chronic lymphocytic leukaemia.
Costanza M., Coutaz C., Cairoli A., Gavillet M., 2023/10. International journal of laboratory hematology, 45 (5) pp. 623-624. Peer-reviewed.
 
Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland.
Schimanski B., Kräuchi R., Stettler J., Lejon Crottet S., Niederhauser C., Clausen F.B., Fontana S., Hodel M., Amylidi-Mohr S., Raio L. et al., 2023/09/27. Biomedicines, 11 (10). Peer-reviewed.
 
Comment on: JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.
Tsilimidos G., Blum S., 2023/09. Annals of hematology, 102 (9) pp. 2619-2620. Peer-reviewed.
 
Myositis manifesting as respiratory insufficiency with anti-RNA polymerase III antibodies: an unusual presentation of graft-versus-host disease.
Wolff L., Clottu A., Mamez A.C., Ribi C., Grandoni F., 2023/09. Leukemia & lymphoma, 64 (9) pp. 1588-1591. Peer-reviewed.
 
Développements récents en hématologie, Partie 2
Duchosal Michel A., Alberio Lorenzo, Angelillo-Scherrer Anne, Arber Caroline, Balabanov Stefan, Blum Sabine, Bttcher Steffen, Buser Andreas, Cairoli Anne, Chalandon Yves et al., 2023/08/23. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Développements récents en hématologie, Teil 1
Duchosal Michel A., Alberio Lorenzo, Angelillo-Scherrer Anne, Arber Caroline, Balabanov Stefan, Blum Sabine, Bttcher Steffen, Buser Andreas, Cairoli Anne, Chalandon Yves et al., 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Insuffisance cardiaque aiguë comme présentation principale d'un syndrome catastrophique des antiphospholipides
Friedrich Bastien P., Burger Raphal, Alberio Lorenzo, Girod Grgoire, Kissling Sbastien, Grandoni Francesco, Graf Guillaume, Ribi Camillo, 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine.
Mencarelli L., Moi L., Dewarrat N., Monti M., Alberio L., Ringwald M., Swierdzewska K., Panagiotis A., Ribi C., 2023/08/07. Vaccines, 11 (8) p. 1335. Peer-reviewed.
 
Consensus report on markers to distinguish procoagulant platelets from apoptotic platelets: communication from the Scientific and Standardization Committee of the ISTH
Josefsson Emma C., Ramström Sofia, Thaler Johannes, Lordkipanidzé Marie, Agbani Ejaife O., Alberio Lorenzo, Bakchoul Tamam, Bouchard Beth A., Camera Marina, Chen Vivien et al., 2023/08. Journal of Thrombosis and Haemostasis, 21 (8) pp. 2291-2299.
Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology.
Angelillo-Scherrer A., Casini A., Studt J.D., Gerber B., Alberio L.A., Fontana P., 2023/07/26. Swiss medical weekly, 153 p. 40113. Peer-reviewed.
Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones.
Rovó A., Gavillet M., Drexler B., Keller P., Schneider J.S., Colucci G., Beauverd Y., van Dorland H.A., Pollak M., Schmidt A. et al., 2023/07. Frontiers in medicine, 10 p. 1200431. Peer-reviewed.
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator.
Burger A., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Bovet C. et al., 2023/06/20. Diagnostics, 13 (12) p. 2128. Peer-reviewed.
 
Thyroid fine needle aspiration for the diagnosis of Langerhans Cell Histiocytosis of the suprasellar region
Sciotto-Canel Lucie, Lopes Stephanie Andrade, Caironi Verdiana, Saiji Essia, Vargas Maria-Isabelle, Jornayvaz Francois R, Momjian Shahan, Stalder Gregoire, Leboulleux Sophie, Mavromati Maria, 2023/05/02. Endocrine Abstracts. Peer-reviewed.
 
Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery: A Randomized Clinical Trial.
Kröll D., Nett P.C., Rommers N., Borbély Y., Deichsel F., Nocito A., Zehetner J., Kessler U., Fringeli Y., Alberio L. et al., 2023/05/01. JAMA network open, 6 (5) pp. e2315241. Peer-reviewed.
Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report.
Gavillet M., Rufer N., Grandoni F., Rizzi M., Vulliemoz N., Baud D., Alberio L., Canellini G., Legardeur H., 2023/05. British journal of haematology, 201 (3) pp. 581-584. Peer-reviewed.
 
Role of Bcl-2 inhibition in myelodysplastic syndromes.
Blum S., Tsilimidos G., Bresser H., Lübbert M., 2023/04/15. International journal of cancer, 152 (8) pp. 1526-1535. Peer-reviewed.
Long-Term Consequences of COVID-19: A 1-Year Analysis.
Bamps L., Armenti J.P., Bojan M., Grandbastien B., von Garnier C., Du Pasquier R., Desgranges F., Papadimitriou-Olivgeris M., Alberio L., Preisig M. et al., 2023/04/03. Journal of clinical medicine, 12 (7) p. 2673. Peer-reviewed.
Identification of High Platelet Reactivity Despite ADP P2Y12 Inhibitor Treatment: Two Populations in the Vasodilator-Stimulated Phosphoprotein Assay and Variable PFA-P2Y Shapes of Curve.
Mariethoz C., Scala E., Matthey-Guirao E., Rossel J.B., Gomez F.J., Grandoni F., Marcucci C., Alberio L., 2023/04. TH open, 7 (2) pp. e143-e154. Peer-reviewed.
Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer.
Fratta S., Biniecka P., Moreno-Vargas A.J., Carmona A.T., Nahimana A., Duchosal M.A., Piacente F., Bruzzone S., Caffa I., Nencioni A. et al., 2023/03/15. European journal of medicinal chemistry, 250 p. 115170. Peer-reviewed.
 
Shall we rethink the timing of epidural anesthesia in anticoagulated obstetrical patients?
Legardeur H., Cuenoud A., Panchaud A., Grandoni F., Mesquita Sauvage A.B., Alberio L., Baud D., Gavillet M., 2023/03. American journal of obstetrics and gynecology, 228 (3) pp. 257-260. Peer-reviewed.
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies.
Biniecka P., Matsumoto S., Belotti A., Joussot J., Bai J.F., Majjigapu S.R., Thoueille P., Spaggiari D., Desfontaine V., Piacente F. et al., 2023/02/16. Molecules, 28 (4) p. 1897. Peer-reviewed.
Caplacizumab for treating subacute intra-stent thrombus occurring despite efficacious double anti-platelet treatment and anticoagulation: a case report.
Stalder G., Chatte A., De Rossi N., Yerly P., Alberio L., Eeckhout E., 2023/02. European heart journal. Case reports, 7 (2) pp. ytac497. Peer-reviewed.
Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia.
Matsumoto S., Biniecka P., Bellotti A., Duchosal M.A., Nahimana A., 2023/01/27. Cancers, 15 (3) p. 787. Peer-reviewed.
Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements.
Papadopoulou V., Schoumans J., Scarpelli I., Blum S., 2023. Acta haematologica, 146 (5) pp. 401-407. Peer-reviewed.
 
Long-standing thrombocytosis often precedes thromboembolic complications heralding the diagnosis of essential thrombocythemia.
Stalder G., Da Silva W.R., Segot A., Blum S., Grandoni F., Alberio L., 2023/01. European journal of internal medicine, 107 pp. 110-112. Peer-reviewed.
 
Perioperative Management of a Patient With Combined Bernard Soulier syndrome and Storage Pool Disease During On-Pump Cardiac Surgery.
Christophel-Plathier E., Costanza M., Kirsch M., Dulguerov F., Chapuis-Bernasconi C., Bisig B., Verdy F., Mendes V., Rancati V., Alberio L. et al., 2023/01. Journal of cardiothoracic and vascular anesthesia, 37 (1) pp. 90-95. Peer-reviewed.
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.
Stalder G., Suffiotti M., Segot A., Noto A., Pantaleo G., Spertini O., Obeid M., 2023/01/01. Haematologica, 108 (1) pp. 234-239. Peer-reviewed.
Thrombophilia and outcomes of venous thromboembolism in older patients.
Méan M., Breakey N., Stalder O., Alberio L., Limacher A., Angelillo-Scherrer A., Fontana P., Beer H.J., Rodondi N., Aujesky D. et al., 2023/01. Research and practice in thrombosis and haemostasis, 7 (1) p. 100015. Peer-reviewed.
 
Gene therapy of Haemophilia: Recommendations from the German, Austrian, and Swiss Society for Thrombosis and Haemostasis Research (GTH) [Erratum: Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)]
Miesbach W., Oldenburg J., Klamroth R., Eichler H., Koscielny J., Holzhauer S., Holstein K., Hovinga JAK, Alberio L., Olivieri M. et al., 2022/12/21. Hamostaseologie, 43 (3) pp. 196-207. Peer-reviewed.
 
Two novel platelet biotinylation methods and their impact on stored platelet concentrates in a blood bank environment.
Muret C., Crettaz D., Martin A., Aliotta A., Bertaggia Calderara D., Alberio L., Prudent M., 2022/11. Transfusion, 62 (11) pp. 2324-2333. Peer-reviewed.
Combinations of rapid immunoassays for a speedy diagnosis of heparin-induced thrombocytopenia.
Rittener-Ruff L., Marchetti M., Matthey-Guirao E., Grandoni F., Gomez F.J., Alberio L., 2022/10. Journal of thrombosis and haemostasis, 20 (10) pp. 2407-2418. Peer-reviewed.
 
Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer.
Bai J.F., Majjigapu S.R., Sordat B., Poty S., Vogel P., Elías-Rodríguez P., Moreno-Vargas A.J., Carmona A.T., Caffa I., Ghanem M. et al., 2022/09/05. European journal of medicinal chemistry, 239 p. 114504. Peer-reviewed.
 
Altered platelet functions during treatment with apremilast for psoriatic arthritis: A case report.
Tsilimidos G., Blum S., Aliotta A., Dumusc A., Alberio L., 2022/09. Current research in translational medicine, 70 (4) p. 103358. Peer-reviewed.
 
Hepatitis B reactivation during ruxolitinib treatment.
Sjoblom M., Chtioui H., Fraga M., Stalder G., Grandoni F., Blum S., 2022/09. Annals of hematology, 101 (9) pp. 2081-2086. Peer-reviewed.
Haematological changes from conception to childbirth: An indicator of major pregnancy complications.
Patxot M., Stojanov M., Ojavee S.E., Pescini Gobert R., Kutalik Z., Gavillet M., Baud D., Robinson M.R., 2022/08. European journal of haematology, 109 (5) pp. 566-575. Peer-reviewed.
TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype.
Ramos-Campoy S., Puiggros A., Kamaso J., Beà S., Bougeon S., Larráyoz M.J., Costa D., Parker H., Rigolin G.M., Blanco M.L. et al., 2022/07/29. Cancers, 14 (15) p. 3715. Peer-reviewed.
Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).
Puiggros A., Ramos-Campoy S., Kamaso J., de la Rosa M., Salido M., Melero C., Rodríguez-Rivera M., Bougeon S., Collado R., Gimeno E. et al., 2022/07/11. Cancers, 14 (14) p. 3376. Peer-reviewed.
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study.
Sathanantham V., Alberio L., Bovet C., Fontana P., Gerber B., Graf L., Mendez A., Sauter T.C., Schmidt A., Studt J.D. et al., 2022/07/11. Life, 12 (7) p. 1027. Peer-reviewed.
Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery.
Ghanem M.S., Caffa I., Del Rio A., Franco J., Parenti M.D., Monacelli F., Cea M., Khalifa A., Nahimana A., Duchosal M.A. et al., 2022/07/10. Pharmaceuticals, 15 (7) p. 848. Peer-reviewed.
Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.
Marchetti M., Barelli S., Gleich T., Gomez F.J., Goodyer M., Grandoni F., Alberio L., 2022/06. British journal of haematology, 197 (6) pp. 766-790. Peer-reviewed.
Pseudoreticulocytosis in a patient with myelodysplastic syndrome.
De Rossi N., Alberio L., Stalder G., 2022/06/01. American journal of hematology, 97 (6) pp. 841-842. Peer-reviewed.
Another piece of knowledge in the puzzle of procoagulant COAT platelets.
Aliotta A., Alberio L., 2022/05. Journal of thrombosis and haemostasis, 20 (5) pp. 1073-1076. Peer-reviewed.
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients.
Obeid M., Suffiotti M., Pellaton C., Bouchaab H., Cairoli A., Salvadé V., Stevenel C., Hottinger R., Pythoud C., Coutechier L. et al., 2022/05/01. JAMA oncology, 8 (5) pp. e220446. Peer-reviewed.
Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP.
Segot A., Adler M., Aliotta A., Matthey-Guirao E., Nagler M., Bertaggia Calderara D., Grandoni F., Gomez F.J., Alberio L., 2022/05. Journal of thrombosis and haemostasis, 20 (5) pp. 1271-1274. Peer-reviewed.
Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia.
ElMokh O., Matsumoto S., Biniecka P., Bellotti A., Schaeuble K., Piacente F., Gallart-Ayala H., Ivanisevic J., Stamenkovic I., Nencioni A. et al., 2022/04/08. Cell death & disease, 13 (4) p. 320. Peer-reviewed.
 
A case of livedoid vasculopathy, a thrombotic occlusive vasculopathy
Huot Anais, Maniu Christa-Maria, Bogiatzi Sofia, Hohl Daniel, Alberio Lorenzo, Stalder Gregoire, 2022/03. JEADV Clinical Practice, 1 (1) pp. 45-48. Peer-reviewed.
 
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients.
Ramos-Campoy S., Puiggros A., Beà S., Bougeon S., Larráyoz M.J., Costa D., Parker H., Rigolin G.M., Ortega M., Blanco M.L. et al., 2022/03/01. Haematologica, 107 (3) pp. 593-603. Peer-reviewed.
EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.
Veloza L., Tsai C.Y., Bisig B., Pantet O., Alberio L., Sempoux C., Cavassini M., de Leval L., 2022/03. Virchows Archiv, 480 (3) pp. 699-705. Peer-reviewed.
Venetoclax combined with FLAG-based chemotherapy induces an early and deep response in mixed-phenotype-acute leukemia.
Ségot A., Stalder G., de Leval L., Solly F., Schoumans J., Basset V., Blum S., Spertini O., 2022/03/01. American journal of hematology, 97 (3) pp. E91-E93. Peer-reviewed.
Mechanisms Underlying Dichotomous Procoagulant COAT Platelet Generation-A Conceptual Review Summarizing Current Knowledge.
Veuthey L., Aliotta A., Bertaggia Calderara D., Pereira Portela C., Alberio L., 2022/02/25. International journal of molecular sciences, 23 (5) p. 2536. Peer-reviewed.
Isolated skin infiltration by a blastic plasmacytoid dendritic cell neoplasm.
Stalder G., Milowich D., Blum S., Schoumans J., Bisig B., Spertini O., 2022/02. EJHaem, 3 (1) pp. 259-260. Peer-reviewed.
 
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mutational Pattern in the Fourth Pandemic Phase in Greece.
Halvatsiotis P., Vassiliu S., Koulouvaris P., Chatzantonaki K., Asonitis K., Charvalos E., Siatelis A., Houhoula D., 2022/01/11. Current issues in molecular biology, 44 (1) pp. 329-335. Peer-reviewed.
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study.
Meihandoest T., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Amstutz U. et al., 2022. Frontiers in cardiovascular medicine, 9 p. 817826. Peer-reviewed.
Blood coagulation alterations over the first 10 days after severe burn injury
Barbier Jeanne M., Viana Marina V., Pantet Olivier, Alberio Lorenzo, Berger Mette M., 2022/01. Burns Open, 6 (1) pp. 10-18.
 
Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
Pouplard C., Rollin J., Vayne C., Charuel N., Ahmadi Z., Alberio L., Azjenberg N., Althaus K., Bakchoul T., Chong B. et al., 2022/01. Journal of thrombosis and haemostasis, 20 (1) pp. 252-259. Peer-reviewed.
Severe Late-Onset Drug-Induced Immune Thrombocytopenia Following IFN β-1a Treatment: A Case Report of a 52-Year-Old Woman with Relapse-Remitting Multiple Sclerosis.
Cisarovsky C., Théaudin M., Bart P.A., Stalder G., Alberio L., 2022. Case reports in hematology, 2022 p. 2767031. Peer-reviewed.
Daratumumab and venetoclax in combination with chemotherapy provide sustained molecular remission in relapsed/refractory CD19, CD20, and CD22 negative acute B lymphoblastic leukemia with KMT2A-AFF1 transcript.
Voruz S., Blum S., de Leval L., Schoumans J., Solly F., Spertini O., 2021/12/20. Biomarker research, 9 (1) p. 92. Peer-reviewed.
Maladie thromboembolique veineuse et grossesse : diagnostic, traitement et suivi [Venous thromboembolic disease during pregnancy : diagnosis, treatment and follow-up]
Vecchio M., Guenot C., Staubli S., Gavillet M., Alberio L., Mazzolai L., Alatri A., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2135-2138. Peer-reviewed.
CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells.
Smirnova T., Spertini C., Spertini O., 2021/10/21. Cancers, 13 (21) p. 5289. Peer-reviewed.
 
High-Dose Epinephrine Enhances Platelet Aggregation at the Expense of Procoagulant Activity.
Aliotta A., Bertaggia Calderara D., Zermatten M.G., Alberio L., 2021/10. Thrombosis and haemostasis, 121 (10) pp. 1337-1344. Peer-reviewed.
 
Successful Rapid Oral Desensitization to Ibrutinib in a Patient With Severe Immediate Hypersensitivity Reaction.
Tsilimidos G., Horisberger A., Ribi C., Cairoli A., Stalder G., 2021/10. Clinical lymphoma, myeloma & leukemia, 21 (10) pp. e745-e747. Peer-reviewed.
 
High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysis.
Halfon M., Artru F., Fraga M., Comte D., Alberio L., Brunet J.F., Fakhouri F., Kissling S., 2021/09. Clinics and research in hepatology and gastroenterology, 45 (5) p. 101734. Peer-reviewed.
 
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients.
Kraljevic M., Khanna N., Medinger M., Passweg J., Masouridi-Levrat S., Chalandon Y., Mueller N.J., Schanz U., Vernaz N., Van Delden C. et al., 2021/07/06. Medical mycology, 59 (7) pp. 701-711. Peer-reviewed.
 
Acute lymphoblastic leukaemia presenting as euglycaemic ketoacidosis in a patient with type 1 diabetes.
Gavillet M., Schaefer N., Lapointe A.K., Spertini O., Cairoli A., 2021/07. The Lancet. Haematology, 8 (7) pp. e534. Peer-reviewed.
Complex Modes of Inheritance in Hereditary Red Blood Cell Disorders: A Case Series Study of 155 Patients.
Andolfo I., Martone S., Rosato B.E., Marra R., Gambale A., Forni G.L., Pinto V., Göransson M., Papadopoulou V., Gavillet M. et al., 2021/06/23. Genes, 12 (7) p. 958. Peer-reviewed.
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation.
Willekens G., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Bovet C. et al., 2021/06. British journal of haematology, 193 (6) pp. 1203-1212. Peer-reviewed.
 
COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Scharf R.E., Alberio L., 2021/06. Hamostaseologie, 41 (3) pp. 179-182. Peer-reviewed.
 
How would we treat our own heparin-induced thrombocytopenia during cardiac surgery?
Koster A., Erdoes G., Nagler M., Birschmann I., Alberio L., 2021/06. Journal of cardiothoracic and vascular anesthesia, 35 (6) pp. 1585-1593. Peer-reviewed.
 
Thrombotic storm under DOAC treatment in a patient with homozygous antithrombin Budapest III mutation.
Condoluci A., Alberio L., Gomez F.J., Studt J.D., Orlando C., Jochmans K., Gerber B., 2021/05. Thrombosis research, 201 pp. 161-163. Peer-reviewed.
 
Recherche d'anticorps anti-PF4/héparine
Parejas Nomie, Alberio Lorenzo, Kraege Vanessa, 2021/04/13. Forum Médical Suisse ‒ Swiss Medical Forum. Peer-reviewed.
 
GTH 2021: The First Online Experience! Useful for Future Meetings?
Alberio L., 2021/04. Hamostaseologie, 41 (2) pp. 100-102. Peer-reviewed.
 
Décompensation cardiaque, arthralgies et prurit généralisé
Tsilimidos Gerasimos, Grandoni Francesco, Blum Sabine, Alberio Lorenzo, Rotman Samuel, Gavillet Mathilde, 2021/03/30. Forum Médical Suisse ‒ Swiss Medical Forum.
Vitamine B12 en pratique : quand tester ? Comment tester ? Et qui substituer ? [Vitamin B12 in practice: When to test ? How to test ? And who should be treated?]
Bruttin J.P., Gilet P., Grandoni F., Alberio L., Favre L., Gavillet M., 2021/03/24. Revue medicale suisse, 17 (731) pp. 582-587. Peer-reviewed.
 
Acquired haemophilia A in the postpartum and risk of relapse in subsequent pregnancies: A systematic literature review.
Dewarrat N., Gavillet M., Angelillo-Scherrer A., Naveiras O., Grandoni F., Tsakiris D.A., Alberio L., Blum S., 2021/03. Haemophilia, 27 (2) pp. 199-210. Peer-reviewed.
 
Sodium-Calcium Exchanger Reverse Mode Sustains Dichotomous Ion Fluxes Required for Procoagulant COAT Platelet Formation.
Aliotta A., Bertaggia Calderara D., Zermatten M.G., Alberio L., 2021/03. Thrombosis and haemostasis, 121 (3) pp. 309-321. Peer-reviewed.
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.
Kuendgen A., Nomdedeu M., Tuechler H., Garcia-Manero G., Komrokji R.S., Sekeres M.A., Della Porta M.G., Cazzola M., DeZern A.E., Roboz G.J. et al., 2021/03. Leukemia, 35 (3) pp. 835-849. Peer-reviewed.
Thrombocytopathies: Not Just Aggregation Defects-The Clinical Relevance of Procoagulant Platelets.
Aliotta A., Bertaggia Calderara D., Zermatten M.G., Marchetti M., Alberio L., 2021/02/24. Journal of clinical medicine, 10 (5) p. 894. Peer-reviewed.
 
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial.
Löwenberg B., Pabst T., Maertens J., Gradowska P., Biemond B.J., Spertini O., Vellenga E., Griskevicius L., Tick L.W., Jongen-Lavrencic M. et al., 2021/02/23. Blood advances, 5 (4) pp. 1110-1121. Peer-reviewed.
Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management.
Marchetti M., Zermatten M.G., Bertaggia Calderara D., Aliotta A., Alberio L., 2021/02/10. Journal of clinical medicine, 10 (4) p. 683. Peer-reviewed.
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS.
Janssen J., Löwenberg B., Manz M., Bargetzi M., Biemond B., Borne PVD, Breems D., Brouwer R., Chalandon Y., Deeren D. et al., 2021/02/07. Cancers, 13 (4) p. 672. Peer-reviewed.
 
GTH 2021: ACROSS BORDERS.
Alberio L., 2021/02. Hamostaseologie, 41 (1) pp. 5-8. Peer-reviewed.
 
Tissue Factor-Independent Coagulation Correlates with Clinical Phenotype in Factor XI Deficiency and Replacement Therapy.
Bertaggia Calderara D., Zermatten M.G., Aliotta A., Batista Mesquita Sauvage A.P., Carle V., Heinis C., Alberio L., 2021/02. Thrombosis and haemostasis, 121 (2) pp. 150-163. Peer-reviewed.
The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation.
Abid K., Popovic M.B., Bourloud K.B., Schoumans J., Grand-Guillaume J., Grouzmann E., Mühlethaler-Mottet A., 2021/01/05. Oncotarget, 12 (1) pp. 49-60. Peer-reviewed.
Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider.
Solari D., Alberio L., Ribi C., Grandoni F., Stalder G., 2021/01. TH open, 5 (1) pp. e8-e13. Peer-reviewed.
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements.
Meihandoest T., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Maeder G.M. et al., 2021. Frontiers in cardiovascular medicine, 8 p. 717939. Peer-reviewed.
 
Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia.
Martins F., Kruszewski M., Scarpelli I., Schoumans J., Spertini O., Lübbert M., Blum S., 2021/01. Annals of hematology, 100 (1) pp. 63-78. Peer-reviewed.
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study.
Leeksma A.C., Baliakas P., Moysiadis T., Puiggros A., Plevova K., Van der Kevie-Kersemaekers A.M., Posthuma H., Rodriguez-Vicente A.E., Tran A.N., Barbany G. et al., 2021/01/01. Haematologica, 106 (1) pp. 87-97. Peer-reviewed.
 
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>.
Klionsky D.J., Abdel-Aziz A.K., Abdelfatah S., Abdellatif M., Abdoli A., Abel S., Abeliovich H., Abildgaard M.H., Abudu Y.P., Acevedo-Arozena A. et al., 2021/01. Autophagy, 17 (1) pp. 1-382. Peer-reviewed.
Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia.
Aliotta A., Krüsi M., Bertaggia Calderara D., Zermatten M.G., Gomez F.J., Batista Mesquita Sauvage A.P., Alberio L., 2020/12/14. International journal of molecular sciences, 21 (24) p. 9515. Peer-reviewed.
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab.
Fontana P., Alberio L., Albisetti M., Angelillo-Scherrer A., Asmis L.M., Casini A., Gerber B., Graf L., Hegemann I., Korte W. et al., 2020/12/14. Swiss medical weekly, 150 pp. w20422. Peer-reviewed.
 
GTH 2021: simply online … worth experiencing.
Alberio L., 2020/12. Hamostaseologie, 40 (5) pp. 558-559. Peer-reviewed.
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
Zermatten Maxime G., Pantet Olivier, Gomez Francisco, Schneider Antoine, Méan Marie, Mazzolai Lucia, Hugli Olivier, Bart Pierre-Alexandre, Papadimitriou-Olivgeris Matthaios, Alberio Lorenzo, 2020/12. Thrombosis Research, 196 pp. 222-226. Peer-reviewed.
 
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.
Fakhouri F., Scully M., Provôt F., Blasco M., Coppo P., Noris M., Paizis K., Kavanagh D., Pène F., Quezada S. et al., 2020/11/05. Blood, 136 (19) pp. 2103-2117. Peer-reviewed.
 
Interprétation du dosage des anticorps anti-phospholipides
Nozic Adnan, Burger Raphael, Alberio Lorenzo, Ribi Camillo, 2020/11/03. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
 
A Collection of Jewels.
Alberio L., 2020/11. Hamostaseologie, 40 (4) pp. 399-400. Peer-reviewed.
 
Emicizumab-Induced Seronegative Full-House Lupus Nephritis in a Child.
Chehade H., Cachat F., Beck-Popovic M., Rotman S., Diezi L., Albisetti M., Alberio L., Young G., Rizzi M., 2020/11. Pediatrics, 146 (5) pp. e20200123. Peer-reviewed.
 
How to Capture the Bleeding Phenotype in FXI-Deficient Patients.
Bertaggia Calderara D., Zermatten M.G., Aliotta A., Alberio L., 2020/11. Hamostaseologie, 40 (4) pp. 491-499. Peer-reviewed.
 
The Art of Detecting Antibodies against Factor VIII.
Tiede A., Alberio L., 2020/11. Hamostaseologie, 40 (4) pp. 485-490. Peer-reviewed.
 
Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.
Voruz S., Gowland P., Eyer C., Widmer N., Abonnenc M., Prudent M., Masouridi-Levrat S., Duchosal M.A., Niederhauser C., 2020/11. Blood transfusion = Trasfusione del sangue, 18 (6) pp. 446-453. Peer-reviewed.
Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.
Fraga M., Moradpour D., Artru F., Romailler E., Tschopp J., Schneider A., Chtioui H., Neerman-Arbez M., Casini A., Alberio L. et al., 2020/10. Journal of hepatology, 73 (4) pp. 967-970. Peer-reviewed.
Utility of the Platelet Function Analyzer in Patients with Suspected Platelet Function Disorders: Diagnostic Accuracy Study.
Kaufmann J., Adler M., Alberio L., Nagler M., 2020/10. TH open, 4 (4) pp. e427-e436. Peer-reviewed.
 
Flow Cytometric Monitoring of Dynamic Cytosolic Calcium, Sodium, and Potassium Fluxes Following Platelet Activation.
Aliotta A., Bertaggia Calderara D., Alberio L., 2020/09. Cytometry. Part A, 97 (9) pp. 933-944. Peer-reviewed.
Management of Full-Thickness Macular Hole in A Genetically Confirmed Case with Usher Syndrome.
Panagiotou E.S., Papathomas T., Nikopoulos K., Koukoula S., Quinodoz M., Rehman A.U., Giannopoulos T., Rivolta C., Konstas A.G., 2020/09. Ophthalmology and therapy, 9 (3) pp. 677-684. Peer-reviewed.
 
Anticoagulants directs
Krähenbühl Marie, Alberio Lorenzo, Kraege Vanessa, 2020/08/26. Forum Médical Suisse ‒ Swiss Medical Forum. Peer-reviewed.
Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.
Stalder G., Alberio L., 2020/08/13. Blood, 136 (7) p. 915. Peer-reviewed.
Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis.
Zermatten M.G., Fraga M., Calderara D.B., Aliotta A., Moradpour D., Alberio L., 2020/08. JHEP reports, 2 (4) p. 100120. Peer-reviewed.
European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH).
Rack K.A., van den Berg E., Haferlach C., Beverloo H.B., Costa D., Espinet B., Foot N., Jeffries S., Martin K., O'Connor S. et al., 2020/08. Leukemia, 34 (8) pp. 2262-2264. Peer-reviewed.
 
Potential and Limitations of the New P2Y12 Inhibitor, Cangrelor, in Preventing Heparin-Induced Platelet Aggregation During Cardiac Surgery: An In Vitro Study.
Scala E., Gerschheimer C., Gomez F.J., Alberio L., Marcucci C., 2020/08. Anesthesia and analgesia, 131 (2) pp. 622-630. Peer-reviewed.
Conidiobolus pachyzygosporus invasive pulmonary infection in a patient with acute myeloid leukemia: case report and review of the literature.
Stavropoulou E., Coste A.T., Beigelman-Aubry C., Letovanec I., Spertini O., Lovis A., Krueger T., Burger R., Bochud P.Y., Lamoth F., 2020/07/22. BMC infectious diseases, 20 (1) p. 527. Peer-reviewed.
Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis.
Artru F., Alberio L., Moradpour D., Stalder G., 2020/07/07. BMJ case reports, 13 (7) pp. e236815. Peer-reviewed.
Long‐term safety and efficacy of N8‐GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2
Giangrande Paul, Abdul Karim Faraizah, Nemes Laszlo, You Chur Woo, Landorph Andrea, Geybels Milan S., Curry Nicola, 2020/06/16. Journal of Thrombosis and Haemostasis.
 
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool.
Gerber A., Da Silva Lopes A., Szüts N., Simon M., Ribordy-Baudat V., Ebneter A., Perrinjaquet C., Gaignard M.E., Nicodet D., Betticher D. et al., 2020/06. Health science reports, 3 (2) pp. e160. Peer-reviewed.
 
Does One Dose Really Fit All? On the Monitoring of Direct Oral Anticoagulants: A Review of the Literature.
Moner-Banet T., Alberio L., Bart P.A., 2020/06. Hamostaseologie, 40 (2) pp. 184-200. Peer-reviewed.
 
Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis.
Zermatten M.G., Fraga M., Moradpour D., Bertaggia Calderara D., Aliotta A., Stirnimann G., De Gottardi A., Alberio L., 2020/06. Hepatology, 71 (6) pp. 2135-2148. Peer-reviewed.
 
L’hématologie au temps du COVID-19 [Hematology in the time of COVID-19]
Gavillet M., Rufer N., Grandoni F., Carr Klappert J., Zermatten M.G., Cairoli A., Canellini G., Alberio L., Duchosal M.A., Spertini O. et al., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 823-826. Peer-reviewed.
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland.
Alberio L., Angelillo-Scherrer A., Asmis L., Casini A., Fontana P., Graf L., Hegemann I., Kremer Hovinga J.A., Korte W., Lecompte T. et al., 2020/04/20. Swiss medical weekly, 150 pp. w20210. Peer-reviewed.
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis.
Casini A., Alberio L., Angelillo-Scherrer A., Fontana P., Gerber B., Graf L., Hegemann I., Korte W., Kremer Hovinga J., Lecompte T. et al., 2020/04/06. Swiss medical weekly, 150 pp. w20247. Peer-reviewed.
 
Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia.
Marchetti M., Barelli S., Zermatten M.G., Monnin-Respen F., Matthey-Guirao E., Nicolas N., Gomez F., Goodyer M., Gerschheimer C., Alberio L., 2020/04/02. Blood, 135 (14) pp. 1171-1184. Peer-reviewed.
 
Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemia.
Flach J., Shumilov E., Joncourt R., Porret N., Tchinda J., Legros M., Scarpelli I., Hewer E., Novak U., Schoumans J. et al., 2020/04. Genes, chromosomes & cancer, 59 (4) pp. 268-274. Peer-reviewed.
 
Comparison of ROTEM Sigma to Standard Laboratory Tests and Development of an Algorithm for the Management of Coagulopathic Bleeding in a Tertiary Center.
Scala E., Coutaz C., Gomez F., Alberio L., Marcucci C., 2020/03. Journal of cardiothoracic and vascular anesthesia, 34 (3) pp. 640-649. Peer-reviewed.
 
Hyper-coagulability in obese patients accurately identified by combinations of global coagulation assay parameters.
Bertaggia Calderara D., Aliotta A., Zermatten M.G., Kröll D., Stirnimann G., Alberio L., 2020/03. Thrombosis research, 187 pp. 91-102. Peer-reviewed.
 
Risk of B-cell lymphoma in MPN patients treated with JAK1/2 inhibitors: Contradictory results?
Costanza M., Spertini O., Blum S., 2020/03. Leukemia research, 90 p. 106313. Peer-reviewed.
Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report.
Zermatten M.G., Bertaggia Calderara D., Aliotta A., Alberio L., 2020/03. Research and practice in thrombosis and haemostasis, 4 (3) pp. 429-432. Peer-reviewed.
 
Rivaroxaban in patients with mechanical heart valves: A pilot study.
Roost E., Weber A., Alberio L., Englberger L., Reineke D., Keller D., Nagler M., Carrel T., 2020/02. Thrombosis research, 186 pp. 1-6. Peer-reviewed.
 
Accuracy of heparin-induced platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia.
Brodard J., Alberio L., Angelillo-Scherrer A., Nagler M., 2020/01. Thrombosis research, 185 pp. 27-30. Peer-reviewed.
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University Hospital.
Kampouri E., Filippidis P., Viala B., Méan M., Pantet O., Desgranges F., Tschopp J., Regina J., Karachalias E., Bianchi C. et al., 2020. BioMed research international, 2020 p. 9126148. Peer-reviewed.
 
Pregnancy with Chuvash Polycythaemia and Other Congenital Erythrocytosis.
Dewarrat N., Kaiser J., Baud D., Alberio L., Gavillet M., 2020. Acta haematologica, 143 (1) pp. 69-72. Peer-reviewed.
Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society.
Tratwal J., Labella R., Bravenboer N., Kerckhofs G., Douni E., Scheller E.L., Badr S., Karampinos D.C., Beck-Cormier S., Palmisano B. et al., 2020. Frontiers in endocrinology, 11 p. 65. Peer-reviewed.
 
Standardization of 8-color flow cytometry across different flow cytometer instruments: A feasibility study in clinical laboratories in Switzerland.
Glier H., Heijnen I., Hauwel M., Dirks J., Quarroz S., Lehmann T., Rovo A., Arn K., Matthes T., Hogan C. et al., 2019/12. Journal of immunological methods, 475 p. 112348. Peer-reviewed.
 
The function of P-selectin glycoprotein ligand-1 is conserved from ancestral fishes to mammals.
Baïsse B., Spertini C., Galisson F., Smirnova T., Spertini O., 2019/12. Journal of leukocyte biology, 106 (6) pp. 1271-1283. Peer-reviewed.
Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent.
Cloux A.J., Aubry D., Heulot M., Widmann C., ElMokh O., Piacente F., Cea M., Nencioni A., Bellotti A., Bouzourène K. et al., 2019/11/19. Oncotarget, 10 (62) pp. 6723-6738. Peer-reviewed.
 
Cardiac Surgery Successfully Managed With Cangrelor in a Patient With Persistent Anti-PF4/Heparin Antibodies 8 Years After Heparin-Induced Thrombocytopenia.
Scala E., Pitta-Gros B., Pantet O., Iafrate M., Kirsch M., Marcucci C., Alberio L., 2019/11. Journal of cardiothoracic and vascular anesthesia, 33 (11) pp. 3073-3077. Peer-reviewed.
 
Transition to 37°C reveals importance of NADPH in mitigating oxidative stress in stored RBCs.
Roch A., Magon N.J., Maire J., Suarna C., Ayer A., Waldvogel S., Imhof B.A., Koury M.J., Stocker R., Schapira M., 2019/11/01. JCI insight, 4 (21) pp. e126376. Peer-reviewed.
 
La TEVAR, un traitement durable des thrombi mobiles de l'aorte descendante?
Kohler Corinne, Wyss Thomas Rudolf, Alberio Lorenzo, Schmidli Jrg, Bhlmann Roman, 2019/10/09. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP.
Davis J., Yan S., Matsushita T., Alberio L., Bassett P., Santagostino E., 2019/10. Journal of medical economics, 22 (10) pp. 1014-1021. Peer-reviewed.
 
Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group Experience.
Solly F., Angelot-Delettre F., Ticchioni M., Geneviève F., Rambaud H., Baseggio L., Plesa A., Debliquis A., Garnache-Ottou F., Roggy A. et al., 2019/09. Cytometry. Part A, 95 (9) pp. 1008-1018. Peer-reviewed.
European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms
Rack K. A., van den Berg E., Haferlach C., Beverloo H. B., Costa D., Espinet B., Foot N., Jeffries S., Martin K., O'Connor S. et al., 2019/08. Leukemia, 33 (8) pp. 1851-1867. Peer-reviewed.
Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders.
Adler M., Kaufmann J., Alberio L., Nagler M., 2019/07. Journal of thrombosis and haemostasis, 17 (7) pp. 1104-1112. Peer-reviewed.
 
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study.
Ghilardi G., Pabst T., Jeker B., Müller R., Cairoli A., Müller AMS, Bargetzi M., Hitz F., Baldomero H., Heim D. et al., 2019/07. Bone marrow transplantation, 54 (7) pp. 1029-1037. Peer-reviewed.
Experimental Drainage Device to Reduce Lymphoedema in a Rat Model.
Triacca V., Pisano M., Lessert C., Petit B., Bouzourene K., Nahimana A., Vozenin M.C., Stergiopulos N., Swartz M.A., Mazzolai L., 2019/06. European journal of vascular and endovascular surgery, 57 (6) pp. 859-867. Peer-reviewed.
 
Primary hepatic marginal B cell lymphoma of mucosa-associated lymphoid tissue (MALT) and non-alcoholic steatohepatitis (NASH): more than a coincidence?
Haefliger S., Milowich D., Sciarra A., Trimeche M., Bouilly J., Kaiser J., Volpi S., Brouland J.P., Sempoux C., de Leval L., 2019/06. Annals of hematology, 98 (6) pp. 1513-1516. Peer-reviewed.
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial.
Poli E.C., Alberio L., Bauer-Doerries A., Marcucci C., Roumy A., Kirsch M., De Stefano E., Liaudet L., Schneider A.G., 2019/04/03. Critical care, 23 (1) p. 108. Peer-reviewed.
Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.
Samaras P., Bargetzi M., Betticher D.C., Driessen C., Duchosal M.A., Heim D., Ketterer N., Lerch E., Matthes T., Mey U. et al., 2019/03/25. Swiss medical weekly, 149 pp. w20031. Peer-reviewed.
The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance.
Vannini N., Campos V., Girotra M., Trachsel V., Rojas-Sutterlin S., Tratwal J., Ragusa S., Stefanidis E., Ryu D., Rainer P.Y. et al., 2019/03/07. Cell stem cell, 24 (3) pp. 405-418.e7. Peer-reviewed.
 
Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin.
Ratano D., Alberio L., Delodder F., Faouzi M., Berger M.M., 2019/03. Thrombosis research, 175 pp. 53-58. Peer-reviewed.
 
Ten-year single-centre experience in fertility preservation of 459 patients suffering from acute leukaemia.
Noetzli J., Voruz S., Wunder D., Primi M.P., Spertini O., Blum S., 2019/03. British journal of haematology, 184 (6) pp. 969-973. Peer-reviewed.
 
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism.
Reiner M.F., Müller D., Gobbato S., Stalder O., Limacher A., Bonetti N.R., Pasterk L., Méan M., Rodondi N., Aujesky D. et al., 2019/02. Thrombosis research, 174 pp. 40-47. Peer-reviewed.
Direct Oral Anticoagulant Drugs: On the Treatment of Cancer-Related Venous Thromboembolism and their Potential Anti-Neoplastic Effect.
Grandoni F., Alberio L., 2019/01/05. Cancers, 11 (1). Peer-reviewed.
Brief Report From the 3rd International Meeting on Bone Marrow Adiposity (BMA 2017).
Corsi A., Palmisano B., Tratwal J., Riminucci M., Naveiras O., 2019. Frontiers in endocrinology, 10 p. 336. Peer-reviewed.
 
Imatinib Uptake into Cells is Not Mediated by Organic Cation Transporters OCT1, OCT2, or OCT3, But is Influenced by Extracellular pH.
Blanc Mettral J., Faller N., Cruchon S., Sottas L., Buclin T., Schild L., Choong E., Nahimana A., Decosterd L.A., 2019. Drug metabolism letters, 13 (2) pp. 102-110. Peer-reviewed.
Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma: From Early Achievements towards New Perspectives.
De Goycoechea D., Stalder G., Martins F., Duchosal M.A., 2019. Journal of oncology, 2019 p. 9513701. Peer-reviewed.
Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation.
Herrera-Gómez F., Del Aguila W., Tejero-Pedregosa A., Adler M., Padilla-Berdugo R., Maurtua-Briseño-Meiggs Á., Pascual J., Pascual M., San Segundo D., Heidt S. et al., 2018/12. Data in brief, 21 pp. 2567-2575. Peer-reviewed.
 
Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen Activation.
Li B., Billur R., Maurer M.C., Kohler H.P., Raddatz Müller P., Alberio L., Schroeder V., 2018/12. Thrombosis and haemostasis, 118 (12) pp. 2037-2045. Peer-reviewed.
 
The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study.
Kröll D., Nett P.C., Borbély Y.M., Schädelin S., Bertaggia Calderara D., Alberio L., Stirnimann G., 2018/12. Surgery for obesity and related diseases, 14 (12) pp. 1890-1896. Peer-reviewed.
 
Generation of procoagulant collagen- and thrombin-activated platelets in platelet concentrates derived from buffy coat: the role of processing, pathogen inactivation, and storage.
Bertaggia Calderara D., Crettaz D., Aliotta A., Barelli S., Tissot J.D., Prudent M., Alberio L., 2018/10. Transfusion, 58 (10) pp. 2395-2406. Peer-reviewed.
MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences.
L'Abbate A., Tolomeo D., Cifola I., Severgnini M., Turchiano A., Augello B., Squeo G., D'Addabbo P., Traversa D., Daniele G. et al., 2018/10. Leukemia, 32 (10) pp. 2152-2166. Peer-reviewed.
 
Over 20 years of treatment-free remission after interferon-alpha monotherapy for chronic myeloid leukemia.
Bloch J., Spertini O., Stucki A., Solly F., Blum S., 2018/10. Leukemia research, 73 pp. 103-104. Peer-reviewed.
Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability.
Pellegrin M., Bouzourène K., Aubert J.F., Nahimana A., Duchosal M.A., Mazzolai L., 2018/09/04. International journal of molecular sciences, 19 (9) pp. E2621. Peer-reviewed.
 
The pseudokinase MLKL activates PAD4-dependent NET formation in necroptotic neutrophils.
D'Cruz A.A., Speir M., Bliss-Moreau M., Dietrich S., Wang S., Chen A.A., Gavillet M., Al-Obeidi A., Lawlor K.E., Vince J.E. et al., 2018/09/04. Science signaling, 11 (546) pp. eaao1716. Peer-reviewed.
 
EDTA-related degranulation mimicking Storage Pool Disease.
Amoruso M., Alberio L., Nagy M., 2018/09. American journal of hematology, 93 (9) pp. 1192-1193. Peer-reviewed.
 
Intramuscular Follicular Lymphoma.
Martins F., Stalder G., Van Der Gucht A., Grandoni F., Cairoli A., 2018/09. Clinical nuclear medicine, 43 (9) pp. 682-684. Peer-reviewed.
Standardized Management Protocol in Severe Postpartum Hemorrhage: A Single-Center Study.
Colucci G., Helsing K., Biasiutti F.D., Raio L., Schmid P., Tsakiris D.A., Eberle B., Surbek D., Lämmle B., Alberio L., 2018/09. Clinical and applied thrombosis/hemostasis, 24 (6) pp. 884-893. Peer-reviewed.
Do hospital doctors test for thrombophilia in patients with venous thromboembolism?
Samim D., Marques-Vidal P., Alberio L., Waeber G., Méan M., 2018/08. Journal of thrombosis and thrombolysis, 46 (2) pp. 238-243. Peer-reviewed.
 
Les lymphohistiocytoses hémophagocytaires [Hemophagocytic Lymphohistiocytosis]
Stalder G., Ribi C., Duchosal M.A., 2018/08. Praxis, 107 (16) pp. 902-911. Peer-reviewed.
 
Circadian variation of ticagrelor-induced platelet inhibition in healthy adulty.
Fournier S., Guenat F., Fournier A., Alberio L., Bonny O., Bertaggia Calderara D., Bardy D., Lauriers N., Harbaoui B., Monney P. et al., 2018/07/01. European heart journal. Cardiovascular pharmacotherapy, 4 (3) pp. 166-171. Peer-reviewed.
High-throughput, nonperturbing quantification of lipid droplets with digital holographic microscopy.
Campos V., Rappaz B., Kuttler F., Turcatti G., Naveiras O., 2018/07. Journal of lipid research, 59 (7) pp. 1301-1310. Peer-reviewed.
Obstructive Hydrocephalus in Newborn Due to Cerebral Atrium Diverticulum Formation: Complete Resolution After Subdural Hematoma Evacuation.
Maduri R., Aureli V., Viaroli E., Rizzi M., Giammattei L., Daniel R.T., Messerer M., 2018/07. World neurosurgery, 115 pp. 338-340. Peer-reviewed.
 
Pseudo Chediak-Higashi anomaly in blasts from acute lymphoblastic leukemia.
Gavillet M., Spertini O., Blum S., 2018/07. Leukemia research, 70 pp. 87-90. Peer-reviewed.
 
Pancytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
Moulin V., Grandoni F., Castioni J., Lu H., 2018/06/14. BMJ case reports, 2018 pp. pii: bcr-2018-225035. Peer-reviewed.
Proteomics of Stored Red Blood Cell Membrane and Storage-Induced Microvesicles Reveals the Association of Flotillin-2 With Band 3 Complexes
Prudent Michel, Delobel Julien, Hübner Aurélie, Benay Corinne, Lion Niels, Tissot Jean-Daniel, 2018/05/04. Frontiers in Physiology, 9 p. 421. Peer-reviewed.
 
Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
Bello C., Bai J., Zambron B.K., Elías-Rodríguez P., Gajate C., Robina I., Caffa I., Cea M., Montecucco F., Nencioni A. et al., 2018/04/25. European journal of medicinal chemistry, 150 pp. 457-478. Peer-reviewed.
 
Reply to: The effect of bariatric surgery on direct-acting oral anticoagulant drug levels.
Kröll D., Alberio L., Stirnimann G., 2018/04. Thrombosis research, 164 pp. 15-16. Peer-reviewed.
 
A key role for Rac and Pak signaling in neutrophil extracellular traps (NETs) formation defines a new potential therapeutic target.
Gavillet M., Martinod K., Renella R., Wagner D.D., Williams D.A., 2018/02. American journal of hematology, 93 (2) pp. 269-276. Peer-reviewed.
Correlation study between osteoporosis and hematopoiesis in the context of adjuvant chemotherapy for breast cancer.
Schyrr F., Wolfer A., Pasquier J., Nicoulaz A.L., Lamy O., Naveiras O., 2018/02. Annals of hematology, 97 (2) pp. 309-317. Peer-reviewed.
 
Effect of Rivaroxaban on thrombin generation in vivo. A study in obese patients.
Bertaggia-Calderara D., Kröll D., Gerschheimer C., Nicolas N., Nett P., Stirnimann G., Alberio L., 2018/02. International journal of laboratory hematology, 40 (1) pp. e11-e14. Peer-reviewed.
Generating the Abscopal Effect by Combining Proapoptotic Peptides With IL-12-Based Immunotherapy.
Martins F., Stalder G., Obeid M., 2018/02. Neoplasia, 20 (2) pp. 193-196. Peer-reviewed.
 
Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013.
Schnegg-Kaufmann A., Feller A., Baldomero H., Rovo A., Manz M.G., Gregor M., Efthymiou A., Bargetzi M., Hess U., Spertini O. et al., 2018/02. Cancer epidemiology, 52 pp. 55-62. Peer-reviewed.
 
Rethinking transfusion medicine with a more holistic approach.
Garraud O., Politis C., Vuk T., Tissot J.D., 2018/02. Transfusion clinique et biologique, 25 (1) pp. 81-82. Peer-reviewed.
Blood and Blood Components: From Similarities to Differences.
Garraud O., Tissot J.D., 2018. Frontiers in medicine, 5 p. 84. Peer-reviewed.
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.
Cagnetta A., Soncini D., Orecchioni S., Talarico G., Minetto P., Guolo F., Retali V., Colombo N., Carminati E., Clavio M. et al., 2018/01. Haematologica, 103 (1) pp. 80-90. Peer-reviewed.
 
Diagnosis and treatment of follicular lymphoma: an update.
Bargetzi M., Baumann R., Cogliatti S., Dietrich P.Y., Duchosal M., Goede J., Hitz F., Konermann C., Lohri A., Mey U. et al., 2018. Swiss medical weekly, 148 pp. w14635. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University